Showing results (981-990 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|February 13, 2008
Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) : a registry for characterizing anaemia management and outcomes in oncology patientsKay Larholt, Chris L Pashos, Qin Wang, et al.
Clinical Drug Investigation|February 13, 2008
Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroidsAlexander Chuchalin, Loretta Jacques, Lucy Frith
Clinical Drug Investigation|February 13, 2008
Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in FranceStéphanie Payet, Philippe Denis, Gilles Berdeaux, et al.
Clinical Drug Investigation|October 10, 2009
Comparison of the pharmacokinetics of apricitabine in the presence and absence of ritonavir-boosted tipranavir: a phase I, open-label, controlled, single-centre studySusan Cox, Justine Southby, Otto Linet, et al.
Clinical Drug Investigation|September 13, 2019
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential FeaturesKatherine A Lyseng-Williamson
Clinical Drug Investigation|February 9, 2021
Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in ItalyFrancesco Saverio Mennini, Andrea Marcellusi, Simone Gazzillo, et al.
Clinical Drug Investigation|February 10, 2021
Correlations Between SGLT-2 Inhibitors and Acute Renal Failure by Signal Detection Using FAERS: Stratified Analysis for Reporting Country and Concomitant DrugsYukari Katsuhara, Shunya Ikeda
Clinical Drug Investigation|February 18, 2021
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient PopulationsNina Shah, Matthew Sussman, Concetta Crivera, et al.
Clinical Drug Investigation|October 28, 2016
Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy VolunteersSrini Ramanathan, Julie A Di Paolo, Feng Jin, et al.
Clinical Drug Investigation|December 9, 2016
Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in ChinaKeng Lai, Chi Zhang, Weixia Ke, et al.
Pageof 234